Citation Impact
Citing Papers
Upregulation of P2X(7) receptor currents in Müller glial cells during proliferative vitreoretinopathy.
2001
MHC Class I Antigens and Immune Surveillance in Transformed Cells
2007
The Retinal Pigment Epithelium in Visual Function
2005 Standout
Immunosuppressive networks in the tumour environment and their therapeutic relevance
2005 Standout
Ido expression by dendritic cells: tolerance and tryptophan catabolism
2004 Standout
Developmental regulation of adenosine A1 receptors, uptake sites and endogenous adenosine in the chick retina
1992
Clinical and pathological heterogeneity in cutaneous gamma-delta T-cell lymphoma: a report of three cases and a review of the literature
1996
Active immunization against cancer with dendritic cells: The near future
2001 StandoutNobel
Survival in small intestinal adenocarcinoma
1996 Standout
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
TRPV3 in keratinocytes transmits temperature information to sensory neurons via ATP
2009 StandoutNobel
Perspectives on the Role of Mhc Antigens in Normal and Malignant Cell Development
1989
TGF-β signaling in tumor suppression and cancer progression
2001 Standout
Cancer immunotherapy: breaking the barriers to harvest the crop
2004 StandoutNobel
WHO-EORTC classification for cutaneous lymphomas
2005 Standout
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
2018 Standout
ATP‐evoked calcium responses of radial glial (Müller) cells in the postnatal rabbit retina
2002
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase
2003 Standout
Mycosis fungoides expressing γ/δ T-cell receptors
1996
The HLA crossroad in tumor immunology
2000
Renewal of photoreceptor outer segments and their phagocytosis by theretinal pigment epithelium
2000
Neuron‐specific distribution of P2X7 purinergic receptors in the monkey retina
2003
DIFFERENT PATTERNS OF HLA‐DR ANTIGEN EXPRESSION IN NORMAL EPITHELIUM, HYPERPLASTIC AND NEOPLASTIC MALIGNANT LESIONS OF THE BREAST
1995
Cancer immunotherapy: moving beyond current vaccines
2004 Standout
Implications for immunosurveillance of altered HLA class I phenotypes in human tumours
1997
OFF‐cholinergic‐pathway‐selective localization of P2X2 purinoceptors in the mouse retina
2004
Modulation of extracellular GABA levels in the retina by activation of glial P2X‐purinoceptors
1998
Nitric oxide in the eye: Multifaceted roles and diverse outcomes
1997
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
In search of the ‘missing self’: MHC molecules and NK cell recognition
1990 Standout
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Purinergic signalling in neuron–glia interactions
2006
T Cell Surveillance of Oncogene-Induced Prostate Cancer Is Impeded by T Cell-Derived TGF-β1 Cytokine
2011 StandoutNobel
Müller cells in the healthy and diseased retina
2006 Standout
Targeted therapy of solid malignancies via HLA class II antigens: a new biotherapeutic approach?
2003
Mechanisms of Immune Evasion by Tumors
2006
Tumor Heterogeneity and Immunotherapy of Cancer
1995
The STATs of cancer — new molecular targets come of age
2004 Standout
Regulatory T cells in tumor immunity
2010 StandoutNobel
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
2009 Standout
Antitumor immune response by CX3CL1 fractalkine gene transfer depends on both NK and T cells
2005 StandoutNobel
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
2001 StandoutNature
MHC class I antigens, immune surveillance, and tumor immune escape
2003
Identification and characterization of P2Y2 nucleotide receptors in human retinal pigment epithelial cells
1997
MHC antigens and tumor escape from immune surveillance
2001
ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria
2011 Standout
Modulation by endogenous ATP of the light‐evoked release of ACh from retinal cholinergic neurones
1994
Kinetic parameters for small-molecule drug delivery by covalent cell surface targeting
2001 StandoutNobel
Colocalization of (3H)-adenosine accumulation and GABA immunoreactivity in the chicken and rabbit retinas
1987
The Immunobiology of Cancer Immunosurveillance and Immunoediting
2004 Standout
Regional differences in the electrically stimulated release of endogenous and radioactive adenosine and purine derivatives from rat brain slices
1990
Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
2009 Standout
NF-κB: linking inflammation and immunity to cancer development and progression
2005 Standout
Escape of Human Solid Tumors from T–Cell Recognition: Molecular Mechanisms and Functional Significance
1999
Purification of mRNA Encoding Chimeric Antigen Receptor Is Critical for Generation of a Robust T-Cell Response
2018 StandoutNobel
The Role and Regulation of Adenosine in the Central Nervous System
2001 Standout
NK CELL RECOGNITION
2004 Standout
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
2006 StandoutScience
Immunological Surveillance of Tumors in the Context of Major Histocompatibility Complex Restriction of T Cell Function
1984 StandoutNobel
Receptors for Purines and Pyrimidines
1998 Standout
The CD8+ Dendritic Cell Subset Selectively Endocytoses Dying Cells in Culture and In Vivo
2002 StandoutNobel
γδ T‐cell lymphomas: a homogeneous entity?
2000
Molecular Physiology of P2X Receptors
2002 Standout
The Three Es of Cancer Immunoediting
2004 Standout
NK CELL RECEPTORS
1998 Standout
Activating Receptors and Coreceptors Involved in Human Natural Killer Cell-Mediated Cytolysis
2001 Standout
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer.
1997 Standout
Upregulation of extracellular ATP-induced Müller cell responses in a dispase model of proliferative vitreoretinopathy.
2002
Loss of H-2Kk gene product(s) from an AKR spontaneous leukaemia
1979
Human Dendritic Cells Activate Resting Natural Killer (NK) Cells and Are Recognized via the NKp30 Receptor by Activated NK Cells
2002 StandoutNobel
The Science behind 25 Years of Ovarian Stimulation for in Vitro Fertilization
2006
Stimulation of A2 adenosine receptors inhibits the ingestion of photoreceptor outer segments by retinal pigment epithelium.
1994
Update on Uses and Properties of Citrus Flavonoids: New Findings in Anticancer, Cardiovascular, and Anti-inflammatory Activity
2008 Standout
The Effect of Female Sex Hormones on Cancer Survival
1990
Transforming growth factor-beta down-regulates major histocompatibility complex class I antigen expression and increases the susceptibility of uveal melanoma cells to natural killer cell-mediated cytolysis.
1995
Characterization of ATP release from cultures enriched in cholinergic amacrine-like neurons
1999
Does the Immune System See Tumors as Foreign or Self?
2003
Nonhepatosplenic gammadelta T-cell lymphoma: a subset of cytotoxic lymphomas with mucosal or skin localization.
1998
TRANSFORMING GROWTH FACTOR-β REGULATION OF IMMUNE RESPONSES
2005 Standout
ATP induces proliferation of retinal cells in culture via activation of PKC and extracellular signal‐regulated kinase cascade
2002
NK cell–mediated killing of target cells triggers robust antigen-specific T cell–mediated and humoral responses
2009 StandoutNobel
Behavioral characteristics of centrally administered adenosine analogs
1986
Glucocorticoid-Induced TNF Receptor Family Related Gene Activation Overcomes Tolerance/Ignorance to Melanoma Differentiation Antigens and Enhances Antitumor Immunity
2006 StandoutNobel
Physiology of Microglia
2011 Standout
Immunogenic Cell Death in Cancer Therapy
2012 Standout
The Modulation of B16BL6 Melanoma Metastasis Is Not Directly Mediated by Cytolytic Activity of Natural Killer Cells in Alcohol‐Consuming Mice
2000
Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?
2012 Standout
Works of M. Pérez being referenced
Correlations of unique clinical, immunotypic, and histologic findings in cutaneous gamma/delta T-cell lymphoma
1992
A weakly tumorigenic phenotype with high mhc class‐i expression is associated with high metastatic potential after surgical removal of the primary murine fibrosarcoma
1990
Heterogeneity of MHC-class-I antigens in clones of methylcholanthrene-induced tumors. Implications for local growth and metastasis
1991
Luteal cytoplasmic estradiol and progesterone receptors in human endometrium: in vitro fertilization and normal cycles
1989
NK sensitivity and lung clearance of MHC‐class‐I‐deficient cells within a heterogeneous fibrosarcoma
1989
Generation and control of metastasis in experimental tumor systems; inhibition of experimental metastases by a tilorone analogue
1993
Localisation of neuronal nitric oxide synthase-immunoreactivity in rat and rabbit retinas
1995
Autoradiography of nucleoside uptake into the retina
1984
HETEROGENEITY OF THE EXPRESSION OF CLASS I AND II HLA ANTIGENS IN HUMAN BREAST CARCINOMA
1986
IMMUNOGENICITY OF H‐2 POSITIVE AND H‐2 NEGATIVE CLONES OF A MOUSE TUMOUR, GR9
1986
Stimulation-evoked release of purines from the rabbit retina
1988
Influence of class I H-2 gene expression on local tumor growth. Description of a model obtained from clones derived from a solid BALB/c tumor.
1986
ABSENCE OF FOUR H‐2d ANTIGENIC SPECIFICITIES IN AN H‐2d SARCOMA
1979
Release of endogenous and radioactive purines from the rabbit retina
1986